Multiomics Market worth $239.92 billion by 2030, growing at a CAGR of 16.26% - Exclusive Report by 360iResearch

The "Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Multiomics Market to grow from USD 83.55 billion in 2023 to USD 239.92 billion by 2030, at a CAGR of 16.26%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/multiomics?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Multiomics integrates various types of biological data, including several omics, such as genomics, transcriptomics, and metabolomics, to comprehensively understand cellular functions, disease mechanisms, and potential therapeutic targets. Multiomics explains complex biological systems by studying the interaction and function between the different molecular compounds. Growing advancements in omics technologies such as next-generation sequencing (NGS), mass spectrometry-based proteomics, high-throughput gene expression profiling platforms, and bioinformatics tools for data integration is expanding the usage of multiomics. Additionally, the increased adoption of personalized medicine, which relies on a deep understanding of individual genetic makeup and response to various drugs, is expanding the scope of multiomics discipline. Furthermore, growing investments in research & development (R&D) activities from the public and private sectors to discover new biomarkers drive market growth. The high cost of handling massive datasets generated from different omics platforms, which often require high-performance computing infrastructure and advanced bioinformatics tools for accurate interpretation, is hampering the market growth. The increasing integration of ML and AI algorithms into multiomics data analysis, which revolutionizes drug discovery processes by identifying novel targets and predicting patient responses, is expected to bolster the growth of the multiomics market.

The availability of well-established healthcare infrastructure and advanced regulatory frameworks that support research and development activities across the U.S., Canada, and Brazil is expanding the scope of the multiomics in the Americas. Pharmaceutical companies in the region are increasingly collaborating with research institutions to develop innovative solutions for precision medicine using multiomics technologies, thereby benefiting the multiomics market in the Americas. Increasing investments in biotechnology research, growing awareness about personalized medicine among patients, and favorable government initiatives to promote healthcare advancements are creating a platform for the multiomics market in Asia-Pacific. In the EMEA region, expanding advanced medical infrastructure and a growing focus on precision medicine research are expanding market growth. The European Union has implemented the General Data Protection Regulation (GDPR) that affects data handling and storage for multiomics studies, making it essential for manufacturers to comply with these regulations.

Market Segmentation & Coverage:

This research report categorizes the Multiomics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables, Instrument, and Software. The Software is projected to witness significant market share during forecast period.

Based on Type, market is studied across Epigenomics, Genomics, Metabolomics, Microbiomics, Proteomics, and Transcriptomics. The Epigenomics is projected to witness significant market share during forecast period.

Based on Application, market is studied across Agriculture & Plant Science, Diagnostics, Drug Discovery, and Precision Medicine. The Precision Medicine is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Biotechnology Companies, Hospitals & Clinics, and Pharmaceutical & Biopharmaceutical Companies. The Biotechnology Companies is further studied across Agriculture, Environmental Science, Forensics, and Plant & Animal Breeding. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/multiomics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Multiomics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Multiomics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Multiomics Market, by Product
7. Multiomics Market, by Type
8. Multiomics Market, by Application
9. Multiomics Market, by End-User
10. Americas Multiomics Market
11. Asia-Pacific Multiomics Market
12. Europe, Middle East & Africa Multiomics Market
13. Competitive Landscape
14. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Multiomics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Multiomics Market?
3. What is the competitive strategic window for opportunities in the Multiomics Market?
4. What are the technology trends and regulatory frameworks in the Multiomics Market?
5. What is the market share of the leading vendors in the Multiomics Market?
6. What modes and strategic moves are considered suitable for entering the Multiomics Market?

Read More @ https://www.360iresearch.com/library/intelligence/multiomics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.